thyssenkrupp nucera Returns to Profit Despite Sales Decline in 2024/2025 Fiscal Year

Based on preliminary, unaudited figures, thyssenkrupp nucera's operating business continued to perform well in the 2024/2025 reporting year, with the world's leading provider of electrolysis technologies returning to profitability despite a slight decline in sales. The company is expected to achieve earnings before interest and taxes (EBIT) of approximately €2 million, a significant improvement from the negative €14 million EBIT reported in the 2023/2024 reporting year. Sales are projected to reach €845 million, slightly below the previous year's €862 million and falling short of the company's original forecast range of €850 million to €920 million.

The Green Hydrogen (gH2) business segment, which utilizes alkaline water electrolysis technology to produce climate-neutral hydrogen, showed substantial improvement in profitability despite declining sales. The segment achieved sales of €459 million compared to €524 million in the prior year, while EBIT improved significantly to negative €56 million from negative €76 million in the previous period. In contrast, the Chlor-Alkali (CA) segment demonstrated strong sales growth, increasing by double digits to €386 million from €338 million in the previous year, though EBIT declined slightly to an estimated €58 million from €62 million.

Order intake for the 2024/2025 fiscal year is expected to total €348 million, a substantial decrease from the previous year's €636 million. The gH2 segment accounted for only €26 million of this total, down dramatically from €356 million in the prior year, while the CA segment saw order intake increase to €322 million from €279 million. The order backlog as of September 30, 2025, stood at €0.6 billion, compared to €1.1 billion in the previous year, reflecting the challenging market conditions affecting the green hydrogen sector.

Looking ahead to the 2025/2026 fiscal year, the Management Board anticipates consolidated sales to decline significantly to between €500 million and €600 million, with consolidated EBIT expected to range from negative €30 million to break-even. The company has already initiated measures to reduce the impact of lower cost coverage resulting from declining sales on consolidated earnings. CEO Dr. Werner Ponikwar acknowledged the increasingly challenging market conditions for green hydrogen, citing continued restraint in final investment decisions and a deteriorating global economic environment. Detailed explanations of the financial performance indicators used can be found in thyssenkrupp nucera's 2023/2024 Annual Report available at https://www.thyssenkrupp-nucera.com/investor-relations/publications.

The company maintains confidence in its ability to navigate current challenges, citing its excellent positioning in both hydrogen and chlor-alkali markets and strong financial resilience. Detailed Q4/FY 2024/2025 results and the complete sales and earnings forecast for the 2025/2026 fiscal year will be published in the 2024/2025 Annual Report on December 17, 2025. The original release containing these preliminary figures is available at https://www.newmediawire.com, providing additional context for investors and stakeholders following the company's performance in the evolving clean energy technology sector.